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Differential effects of Sendai virus infection on mediator syn-
thesis by mesangial cells from two mouse strains.
Background. Recently, we observed that the severity of glo-
merulonephritis in an experimental model of immunoglobulin
A nephropathy (IgAN) induced by Sendai virus differs be-
tween C57BL/6 and BALB/c mouse strains. The determinants
of differing renal insufficiency are not understood. In the pres-
ent study, we examine the capacity for mesangial cells to sup-
port Sendai viral replication and assess the direct effects of
Sendai virus on the production of selected cytokines, chemo-
kines, and eicosanoids by mesangial cells, comparing C57BL/6
to BALB/c mouse strains.
Methods. Sendai virus replication was measured by viral
plaque assay using LLCMK2 cells. Production of cytokines
[interleukin-6 (IL-6) and tumor necrosis factor- (TNF-)],
chemokines (JE and KC), and eicosanoids [prostaglandin E2
(PGE2) and thromboxane B2 (TxB2)] in culture medium was
evaluated by sandwich enzyme-linked immunosorbent assay
(ELISA) or competitive enzyme immunoassay (EIA) after 48
hours’ incubation with infectious or inactivated Sendai virus.
Results. Sendai virus replicates equally well in mesangial
cells from both strains, and infection evokes increased IL-6,
JE, KC, and PGE2 production in relation to viral dose. BALB/c
mesangial cells produce significantly more IL-6 and JE than
those from C57BL/6, and the dose response for KC is steeper
in BALB/c mesangial cells than those from C57BL/6. Synthesis
of PGE2 in BALB/c mesangial cells is higher than that of
C57BL/6 mesangial cells, both under basal conditions and in
response to infectious Sendai virus, again in a dose-dependent
manner. There is no TNF- or thromboxane response to viral
stimulation.
Conclusion. We conclude that different mesangial cell re-
sponses to this common mucosal viral pathogen might influence
the severity of IgAN in our model system.
Immunoglobulin A nephropathy (IgAN), the most
common form of glomerulonephritis in the world, is a
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mesangial proliferative glomerulonephritis character-
ized by granular deposition of predominantly IgA and
C3 in the glomerular mesangium [1–5]. Although IgAN
is now recognized as a major cause of end-stage renal
disease (ESRD), its pathogenetic mechanisms remain
obscure [1–5]. To date, the characteristics of the depos-
ited IgA as antibody and the functional responses of
mesangial cells to this IgA, other immunoglobulin co-
deposits, complement, and antigens have been exten-
sively investigated [1–5].
Most patients with IgAN initially manifest disease and
develop exacerbation in association with acute illnesses,
apparently infections, involving the respiratory and/or
gastrointestinal tract. Several lines of evidence suggest
that IgAN represents an immune complex disease insti-
gated by specific IgA antibody bound to antigens derived
from mucosal pathogens [1–4, 6]. However, only a small
minority of individuals with mucosal infections develops
IgAN. Therefore, some research on the pathogenesis of
IgAN has focused on regulation of the mucosal immune
response to viral or bacterial pathogens [1, 2, 7–9]. Re-
cently, the principle that defective regulation of mucosal
immunity underlies the genesis of IgAN [1, 2, 4] has
gained wider acceptance and clinical corroboration [10–12].
We recently developed a murine model of IgAN induced
by Sendai virus, a parainfluenza virus similar to human
respiratory viruses [13], to probe infection-related IgAN
and identify mechanisms potentially responsible for
IgAN [1, 2, 6, 9]. In this experimental system, the fre-
quency of nephritis is similar among several mouse
strains, but BALB/c mice develop more severe nephritis
with acute renal insufficiency than C3HeB and C57BL/6
mice, which rarely develop renal insufficiency [9]. Since
glomerular mesangial immune deposits predominate
both in the murine model induced by Sendai virus and
in naturally occurring IgAN in patients [1, 2], interaction
of mesangial cells with virus could be a critical determi-
nant of disease. Accordingly, we postulated that geneti-
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cally determined differences in the response of mesangial
cells to virus or viral antigens underlie the different se-
verity of nephritis that develops in different mouse
strains upon Sendai virus infection. Therefore, we com-
pared the capacity for Sendai virus to generate a produc-
tive infection of mesangial cells and/or elicit release of
inflammatory mediators from C57BL/6 and BALB/c
mesangial cells.
In response to diverse stimuli, mesangial cells produce
a broad variety of inflammatory mediators [14–26], many
of which are increased in renal tissue and/or urine in
glomerulonephritis. Moreover, there is evidence that
some of these factors play functional roles. Notably,
there is increased interleukin-6 (IL-6) expression by re-
nal tissues in IgAN; production of IL-6 appears to both
induce and serve as a marker of mesangial cell prolifera-
tion [19, 21, 27–29]. Furthermore, the production of che-
mokines such as monocyte chemoattractant protein-1
(MCP-1), IL-8, and interferon-induced protein 10 (IP-10)
by mesangial cells in IgAN and other glomerulonephri-
tides might contribute to infiltration of macrophages or
neutrophils into glomeruli, and thereby modulate glo-
merular damage [14, 22, 25, 26, 30–33]. Therefore, we
focused on the potential for mesangial cells to produce
inflammatory mediators implicated in pathogenesis in
response to stimulation with Sendai virus, comparing
C57BL/6 to BALB/c mesangial cells.
METHODS
Cell cultures
Mesangial cells were cultured from isolated mouse
glomeruli, essentially as previously described [14, 34].
Renal cortices (10 mice per primary culture) from female
C57BL/6 or BALB/c mice (The Jackson Laboratory, Bar
Harbor, ME, USA), 6 weeks of age, were dissected from
the medulla and capsule, minced to a paste, gently
pressed through a 75 m steel sieve and then suspended
in Hanks’ balanced salt solution (HBSS) (Life Technolo-
gies, Rockville, MD, USA) without calcium or magne-
sium. The suspension was passed repetitively through a
26-gauge needle and through a 106 m steel sieve to
remove large tissue fragments. Glomeruli, retained on
a 70 m nylon sieve, were incubated with 750 U/mL
collagenase (type IA) (Sigma Chemical Co., St. Louis,
MO, USA) in HBSS without calcium or magnesium at
37C for 25 minutes. After centrifugation (200  g)
(SORVALL, RT 6000B) (Kendro Laboratory Prod-
ucts, Newtown, CT, USA) at 4C for 3 minutes, glomeruli
were resuspended in 6 mL of RPMI 1640 (Life Technolo-
gies) supplemented with ITS Pre-mix (0.55 g/mL
transferrin, 1g/mL insulin, and 0.67 ng/mL selenium-A)
and with 100 U/mL penicillin, 100 g/mL streptomycin,
and 17% fetal bovine serum (FBS) (all supplements from
Life Technologies). Equal volumes (1 mL) of this suspen-
sion were plated into individual wells in a 6-well culture
plate. Cultures were incubated at 37C in a 5% CO2 con-
ditioned humidified atmosphere, and subcultured in 75 cm2
flasks using the same medium with 10% FBS.
Sendai virus
Sendai virus strain 52 (ATCC catalog No. VR-105,
American Type Culture Collection, Rockville, MD,
USA) was propagated in 11-day-old embryonated eggs
as described [35, 36]. Virus was purified from allantoic
fluid after ultracentrifugation and stored at 70C. For
inactivation, virus was treated for 18 hours at 4C with
0.05% -propriolactone, and then incubated for 1 hour
at 37C to detoxify -propriolactone. Infectious virus
was quantified by plaque assay, and the protein concen-
trations in both infectious and inactivated virus suspen-
sions were determined as described [35].
Viral titers
LLCMK2 monkey kidney cells were propagated in
medium 199 (M199) supplemented with 5% FBS, 2
mmol/L glutamine, 100 U/mL penicillin, and 100 g/mL
streptomycin. Plaque assay for virus was performed as
previously detailed [35, 36]. Mesangial cell supernatants
were incubated with trypsin [four parts supernatant and
one part 12.5 g/mL trypsin] for 30 minutes at 37C and
added to LLCMK2 cells for 90 minutes at 37C. The
inoculum was removed, and the cells were overlaid with
2 mL of M199 containing no serum, 0.5% Bacto Agar
(Difco Laboratories, Detroit, MI, USA), and 2.5 g/mL
of trypsin (Life Technologies). Plaques were visualized
after 3 days by hemadsorption with a 0.001% suspension
of freshly washed and pelleted guinea pig red blood
cells. The virus titer for each sample (suspension, culture
medium, or cell lysate) was calculated as the common
logarithm of the number of plaques [35, 36].
Limulus amebocyte lysate test (LAL test)
Endotoxin was measured using an end point method
with diazo-coupling (Pyrochrome) (Associates of Cape
Cod, Inc., Falmouth, MA, USA). Briefly, 50 L of infec-
tious or inactivated virus suspension or endotoxin stan-
dard at varying concentrations were incubated with
50 L of Pyrochrome [a proprietary mixture of limulus
polyphemus extract, dextran, ethylenediaminetetraace-
tic acid (EDTA), CaCl2 and Boc-Leu-Gly-Arg-p-nitro-
anilide with 0.2 mol/L Tris (hydroxymethyl)-aminometh-
ane HCl, pH 8] for 47 minutes at 37C in 96-well
microplates (Associates of Cape Cod, Inc.). After incu-
bation, 50 L of 0.4 mg/mL sodium nitrite in 0.48 N
HCl, 3 mg/mL ammonium sulfamate, and 0.7 mg/mL
N-(naphthyl) ethylenediamine dihydrochloride were
added to each well. The optical density at 550 nm was
determined in a microplate reader (Bio-Kinetics Reader
Model EL312) (Bio-Tek Instruments, Inc., Winooski,
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VT, USA). Endotoxin concentrations in unknown dupli-
cate samples were determined by interpolation of the
respective optical density into the standard curve.
Experimental protocols
Mesangial cells from C57BL/6 or BALB/c mice were
cultured to near confluence in 6-well culture plates; cell
growth was arrested in RPMI 1640 containing 0.5% FBS
for 24 hours. The cells were incubated in 0.45 mL me-
dium with various numbers of infectious (1.25, 2.5, 5,
and 10 pfu/cell) or inactivated (5 virions/cell) Sendai
virus, or with no virus added. After 2 hours’ incubation,
the supernatants were collected for analysis of prosta-
glandin E2 (PGE2) and thromboxane B2 (TxB2) content.
The cells were washed once with culture medium, and
1 mL fresh culture medium was applied. In several inde-
pendent pilot experiments comparing the response to 5
pfu/cell Sendai virus to medium alone (data not shown),
all mediators reached peak levels after an additional 48
hours in culture. Accordingly, for the definitive experi-
ments presented herein, supernatants and cells were har-
vested for various assays at this time point. Calcium
ionophore A23187 (1 g/mL) or recombinant mouse
IL-1 (500 pg/mL) was added to some cultures as posi-
tive controls for eicosanoid, cytokine or chemokine pro-
duction.
Eicosanoid synthesis
PGE2 and TxB2 content in supernatant from each cul-
ture well were measured in duplicate using a competitive
enzyme immunoassay (EIA) system (Amersham Phar-
macia Biotech Inc, Piscataway, NJ, USA) according to
the manufacturer’s instructions. Briefly, 50 L of super-
natant or standard was incubated for 1 hour at room
temperature on a plate shaker with a fixed mixture of
either mouse anti-PGE2 antibody and PGE2 conjugated
to horseradish peroxidase (HRP) in wells precoated with
a goat antimouse IgG or with rabbit anti-TxB2 antibody
and TxB2- HRP in wells precoated with a donkey antirab-
bit IgG. After washing the plate, 150 L of substrate
solution [3,3,5,5 tetramethylbenzidine (TMB)/hydro-
gen peroxide in 20% (vol/vol) dimethylformamide, pre-
equilibrated at room temperature] was added for 30
(PGE2) or 15 (TxB2) minutes. Following the addition of
100 L 2 N sulfuric acid to all wells, the optical density
at 450 nm was determined in a microplate reader (Bio-
Tek Instruments, Inc., Winooski, VT, USA). PGE2 and
TxB2 concentrations in unknown duplicate samples were
determined by interpolation of the respective optical
density into the appropriate standard curve.
Cytokine production
IL-6 and tumor necrosis factor- (TNF-) production
were determined by sandwich enzyme-linked immuno-
sorbent assay (ELISA) (DuoSet) (R&D Systems, Min-
neapolis, MN, USA) according to the manufacturer’s
instructions. All incubations were performed at room
temperature. Briefly, 96-well microplates were coated
with 2 g/mL rat antimouse IL-6 or 0.8 g/mL goat
antimouse TNF- antibody in phosphate-buffered saline
(PBS) overnight. After three washes (0.05% Tween 20
in PBS, pH 7.4), the plates were blocked by adding 1%
bovine serum albumin (BSA), 5% sucrose in PBS with
0.05% NaN3 to the wells for 1 hour. Plates were washed
three times, and 100 L of sample or standard was incu-
bated for 2 hours. After three washes, biotinylated goat
antimouse IL-6 antibody (200 ng/mL) or goat antimouse
TNF- antibody (300 ng/mL) in 1% BSA in PBS was
incubated for 2 hours. Plates were washed three times
and developed with an HRP-conjugated streptavidin,
followed by substrate solution (1:1 mixture of TMB and
hydrogen peroxide) (R&D Systems). Interferon- (IFN-)
content in supernatant from each culture well was mea-
sured using a sandwich ELISA Kit with proprietary for-
mulations, according to the manufacturer’s instructions
(R&D Systems). Based on pilot experiments, samples
from incubations with infectious virus were diluted 1:2;
all others were assayed undiluted. Cytokine concentra-
tions in unknown duplicate samples were determined by
interpolation of the respective optical density into the
appropriate standard curve.
Chemokine production
The concentrations of JE and KC, the murine homo-
logs of human MCP-1 and IL-8, respectively, were mea-
sured by sandwich ELISA according to the manufactur-
er’s instructions (DuoSet) (R&D Systems). Capture
and detection antibodies for JE (0.2 g/mL goat anti-
mouse JE and 50 ng/mL biotinylated goat antimouse
JE) or KC (2 g/mL rat antimouse KC and 200 ng/mL
biotinylated goat antimouse KC) were utilized for assays
otherwise the same as those for cytokine measurement.
Murine interferon-inducible protein-10 (IP-10) was de-
termined using a previously published protocol [37].
Assessment of mesangial cell proliferation
Mesangial cell proliferation was determined at 48 or
72 hours of incubation by direct counting of trypan blue–
excluding cells in a hemocytometer and, in parallel cul-
tures, by bioreduction of a tetrazolium salt (CellTiter
96 AQueous One Solution Cell Proliferation Assay) (Pro-
mega, Madison, WI, USA). Cellular protein was quanti-
fied by dye binding (BCA Protein Assay Kit) (Pierce,
Rockford, IL, USA). To assess the effect of endogenous
IL-6 on proliferation, parallel wells were incubated in
the presence of 15 ng/mL monoclonal rat antimouse IL-6
neutralizing antibody (R&D Systems). As a positive con-
trol for IL-6–induced cell proliferation, 200 pg/mL of
recombinant mouse IL-6 (R&D Systems) was added to
additional culture wells.
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Statistics and data analysis
Two independent cell cultures were established from
each of the two strains of mice at separate times from
distinct groups of animals (four separate primary explant
cultures in all). In each of the four experiments, triplicate
culture wells for each of six incubation conditions (four
levels of infectious virus, a single level of inactivated virus
or medium control) were established. Each individual
supernatant sample was assayed in duplicate for each
analyte, and the arithmetic mean of the duplicates was
taken as the result for the individual well. Three-way
analysis of variance (ANOVA) (stratified for strain,
incubation condition, and experiment) and two-way
ANOVA (stratified for the combination of strain and
incubation condition and for experiment) indicated that
there was no significant difference between the two repli-
cate experiments performed with each of the two strains,
except for PGE2 production by BALB/c cells. Accord-
ingly, the data from the two experiments within each
strain were pooled for all but PGE2 synthesis by BALB/c,
and the data plotted in the figures are the mean ( SD)
for the six replicate wells (three in each of two experi-
ments) for each condition in each strain. Three-way
ANOVA (stratified for strain, incubation condition, and
experiment) and two-way ANOVA (stratified for strain
and incubation condition, with the two experiments for
each strain combined) indicate a statistically significant
effect for strain and incubation condition. All t statistics
quoted are Dunnett’s post-hoc ts from one-way ANOVA
(Statview II, Abacus Concepts, Inc., Berkeley, CA, USA);
each stratification group represents a particular combina-
tion of strain and incubation condition. Unless otherwise
specified (e.g., PGE2 results), effects are considered sta-
tistically significant only if the comparison is significant
by one-way ANOVA for each independent experiment
separately (three replicates per incubation condition in
each of the two experiments) and for both experiments
pooled (i.e., six replicates per incubation condition).
RESULTS
Viral titers in culture medium of mouse
mesangial cells
No virus is recovered from mesangial cells inoculated
with inactivated Sendai virus (5 pfu equivalents/cell) or
medium controls. In contrast, copious virus is recovered
from mesangial cells inoculated with infectious (5 pfu/
cell) Sendai virus (t 	 44, P 
 0.001 versus medium
control or cells incubated with inactivated virus), with
no difference between C57BL/6 and BALB/c mesangial
cells [3.66  0.08 and 3.69  0.04 log (pfu/mL), respec-
tively, data not shown].
Endotoxin is undetectable (less than 0.005 endotoxin
units (EU) per mL) in suspensions of either infectious
or inactivated Sendai virus (data not shown).
Fig. 1. Interleukin-6 (IL-6) production by cultured mesangial cells
stimulated with Sendai virus. IL-6 production by C57BL/6 or BALB/c
mesangial cells stimulated with infectious Sendai virus is significantly
higher than with medium alone and increases in a dose (MOI)-depen-
dent manner (*t  5.7 versus the value produced by cells of the same
strain cocultured in medium only, MOI  0 and t  3.3 versus the
values of the immediately lower MOI within the same strain). Mesangial
cells from BALB/c mice produce significantly more IL-6 than those
from C57BL/6 after infectious Sendai virus stimulation (t 6.0 between
strains at the same MOI). Inactivated virus added at an MOI of 5 has
no effect (P  NS versus medium control for both mouse strains). Data
are expressed as mean  SD of two independent experiments for each
strain (i.e., for each plotted point N  6, three for each independent
experiment), harvested at 48 hours after 2 hours’ incubation with virus
(most errors for C57BL/6 are too small to be visualized). Statistical
significances shown are also attained within each individual experiment.
Cytokine responses to Sendai virus
Both C57BL/6 and BALB/c mesangial cells produce
increasing IL-6 in relation to the dose, or multiplicity of
infection (MOI), of infectious Sendai virus added (Fig.
1). At all MOI, IL-6 significantly exceeds the level pro-
duced by cells in medium only. Mesangial cells from
BALB/c mice produce significantly more IL-6 in re-
sponse to infectious virus than those from C57BL/6, even
though C57BL/6 and BALB/c cells produce identical
amounts of IL-6 in response to IL-1 (111 pg/mL, data
not shown). Inactivated Sendai virus (at 5 pfu equiva-
lents/cell) elicits no increase in IL-6 production by either
C57BL/6 or BALB/c mesangial cells relative to the basal
IL-6 level.
No TNF- production is detectable in cultures of mes-
angial cells of either mouse strain under any conditions
tested, even if stimulated by IL-1 (data not shown).
As anticipated, infectious, but not inactivated, virus
evokes heavy production of (type I) IFN-. Supernatants
from C57BL/6 or BALB/c mesangial cells incubated for
48 hours after infection with 5 MOI of Sendai virus
contain 57.5  4.7 pg/mL or 915  54 pg/mL IFN-,
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Fig. 2. JE production by cultured mesangial cells stimulated with Sen-
dai virus. JE production by C57BL/6 or BALB/c mesangial cells stimu-
lated with infectious Sendai virus is significantly higher than in medium
alone, and increases as a function of the MOI (*t 	 6.3 versus the value
for the same strain in medium only, MOI  0 and t 	 5.5 versus the
values of the immediately lower MOI within the same strain), except
for 5 MOI applied to C57BL/6 cells. Mesangial cells from BALB/c mice
produce significantly more JE than those from C57BL/6 after infectious
virus exposure (all t	 8.9 between strains at the same MOI). Inactivated
virus added at an MOI of 5 has no effect (P  NS versus medium
control for both mouse strains). Data are expressed as mean  SD of
two independent experiments for each strain, harvested at 48 hours
after 2 hours’ incubation with virus. Statistical significances shown are
also attained within each individual experiment.
respectively (t  62, P 
 0.001 for C57BL/6 versus
BALB/c), but all supernatants from cells incubated with
5 MOI equivalents of inactivated virus or maintained in
culture medium alone are below the detection threshold
of 12.5 pg/mL (t 	 50, P 
 0.001 for both BALB/c
controls and t 	 2.6, P 
 0.05 for C57BL/6 controls
versus cells infected at 5 MOI, data not shown).
Chemokine responses to Sendai virus
Infectious Sendai virus stimulates JE production by
either C57BL/6 or BALB/c mesangial cells, in relation to
the dose (MOI); all stimulated cultures are significantly
higher than medium controls (Fig. 2). Basal production
of JE by C57BL/6 mesangial cells (421.3  57.1 pg/mL)
is tenfold that produced by BALB/c cells (44.0  8.4
pg/mL), and IL-1 (data not shown) stimulates C57BL/6
mesangial cells to produce fourfold more JE (7460.5 
2122.3 pg/mL) than BALB/c cells (1832.1  484.7
pg/mL). Yet, at all MOI tested, BALB/c cells produce
significantly more JE in response to virus than C57BL/6
cells. When JE production is normalized to total cellu-
lar protein content, the difference between the larger
(and more protein-rich) BALB/c cells and the smaller
C57BL/6 cells is eliminated (data not shown). No signifi-
Fig. 3. KC production by cultured mouse mesangial cells exposed to
Sendai virus. KC production by C57BL/6 or BALB/c mesangial cells
stimulated with higher doses of infectious Sendai virus is significantly
higher than in medium control, and increases at higher MOI (*t 	 4.1
versus the value for the same strain in medium only, MOI  0 and t 	
2.7 versus the values of the immediately lower MOI within the same
strain). No significant difference is detected in KC production by
C57BL/6 mesangial cell between infectious and inactivated virus stimu-
lation at 5 virions/cell. Mesangial cells from C57BL/6 mice produce
significantly more KC than those from BALB/c with 1.25, 2.5, and 5
virions/cell, but BALB/c cells produce more KC at 10 virions/cell (t 
2.3 between strains within the same MOI stimulation). Data are ex-
pressed as mean  SD of two independent experiments for each strain,
harvested at 48 hours after 2 hours’ incubation with virus. Statistical
significances shown are also attained within each individual experiment.
However, addition of 1.25 pfu/cell to BALB/c mesangial cells elicits a
statistically borderline KC response; specifically, although significance
is not achieved in either of the two experiments individually, KC is
significantly increased when the two experiments are pooled.
cant increase in JE production above control is elicited
from either C57BL/6 or BALB/c mesangial cells by inac-
tivated Sendai virus.
Production of KC by both C57BL/6 and BALB/c mes-
angial cells is significantly higher than basal upon stimu-
lation with higher levels (MOI  5 or 10 pfu/cell) of
infectious Sendai virus (Fig. 3). Basal production of KC
by C57BL/6 mesangial cells (220.1  69 pg/mL) is 17-
fold higher than that by BALB/c mesangial cells (13.3 
3.4 pg/mL), and IL-1 elicits threefold higher KC from
C57BL/6 mesangial cells (9980.8  936.3 pg/mL) than
from BALB/c cells (3513.8  802.2 pg/mL, data not
shown). Nonetheless, only BALB/c cells produce sig-
nificantly increased KC in response to lower MOI (2.5
and perhaps 1.25 pfu/cell), and the effect of dose upon
KC response is significantly steeper with BALB/c mesan-
gial cells than with C57BL/6 cells at the higher MOI.
Inactivated Sendai virus (5 pfu equivalents/cell) elicits
heightened KC production by C57BL/6, similar to (P 
NS) an equal amount (5 pfu/cell) of infectious virus, but
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Fig. 4. Prostaglandin E2 (PGE2) synthesis by cultured mouse mesangial
cells stimulated with Sendai virus. At all but the lowest dose of virus
(MOI 1.25), PGE2 synthesis by C57BL/6 mesangial cells (data are
mean  SD from two independent experiments which did not differ
from each other) stimulated with infectious Sendai virus is significantly
higher than control, and increases in relation to the MOI (*t 	 3.3
versus the value for the same strain in medium only, MOI  0 and t 
2.4 versus the values of the immediately lower MOI within the same
strain). PGE2 synthesis by BALB/c mesangial cells (data are mean 
SD from each of two independent experiments) exposed to infectious
Sendai virus is significantly higher than in medium alone (*t 	 3.3
versus the value for the same strain in medium only, MOI  0), except
for 1.25 and 2.5 MOI in experiment 2. Although PGE2 synthesis in-
creases in relation to the MOI, significant dose effect is recognized only
at 10 MOI in experiment 1 (t 2.4 versus the values of the immediately
lower MOI within the same strain). Mesangial cells from BALB/c mice
synthesize significantly more PGE2 than C57BL/6 cells under basal
conditions and in response to infectious and inactivated virus (all t 
3.2 versus between strains within the same MOI stimulation).
does not significantly influence BALB/c mesangial cells
(Fig. 3).
Infectious Sendai virus (5 pfu/cell) evokes synthesis
of IP-10 from both C57BL/6 (4050  1115 pg/mL) and
BALB/c (9044  1885 pg/mL) mesangial cells (both t 	
6.9, P
 0.001 versus syngeneic medium controls). Inacti-
vated virus stimulates trivial (
 700 pg/mL) levels that
do not differ significantly from the lower limit of detec-
tion for the assay (50 pg/mL) or from medium controls.
Again, BALB/c cells respond to virus infection signifi-
cantly (t 9.3, P
 0.001) more vigorously than C57BL/6
mesangial cells.
Eicosanoid responses to Sendai virus
PGE2 synthesis by C57BL/6 mesangial cells upon stim-
ulation with 2.5 pfu Sendai virus/cell increases signifi-
cantly (by 30%), and increases further (by 75% and
108%) at higher MOI (5 and 10 pfu/cell), relative to
medium control (Fig. 4). PGE2 synthesis by C57BL/6
cells in response to inactivated virus (5 pfu equivalents/
cell) is also significantly higher (by 40%) than control,
albeit significantly less than the response (75% increase
relative to basal) to the same number of infectious viri-
ons. Synthesis of PGE2 by BALB/c mesangial cells varies
widely among experiments; we show the results of two
independent representative experiments with BALB/c
mesangial cells individually (Fig. 4). At 5 and 10 pfu/cell,
respectively, infectious virus elicits 55% and 75%
increases in PGE2 synthesis compared to basal levels in
multiple experiments, numerically less than but similar
in character to the response by C57BL/6 mesangial cells.
In contrast to C57BL/6 cells, lower doses (1.25 and 2.5
pfu/cell) of infectious virus and inactivated virus at an
MOI of 5 exert inconsistent effects on PGE2 synthesis
by BALB/c cells. Basal synthesis of PGE2 by BALB/c
mesangial cells is consistently two to three-fold higher
than by C57BL/6 mesangial cells, but the relative re-
sponse to calcium ionophore A23187 is higher in C57BL/6
(4912.2  110.2 pg/mL, eightfold basal) than in BALB/c
cells (4930.3  1411.3 pg/mL, threefold basal). Total
stimulated production is approximately equal in the two
strains.
No change in TxB2 synthesis is observed in response
to any of the stimuli by either strain of mice (data not
shown).
Mesangial cell proliferative responses to Sendai virus
By direct enumeration, BALB/c mesangial cells incu-
bated with infectious virus (5 pfu/cell) exhibit 22% or
24% greater proliferation at 48 and 72 hours, respec-
tively, compared to control cells cultured in medium for
the same period. Viability (by trypan blue exclusion)
remains high and does not differ across incubation condi-
tions or over time. Exogenous IL-6, added at a concentra-
tion (200 pg/mL) somewhat higher than that achieved in
supernatants from cells incubated with infectious virus,
elicits proliferation (20% greater than medium control)
similar to that instigated by infectious virus itself at 72
hours (Table 1). Collateral assessments of cell growth
produce qualitatively similar results (data not shown).
Specifically, over 48 hours, infectious virus elicits a 15%
increase in the reduction of a proprietary tetrazolium
dye relative to cells in medium alone (t  4.63, P 

0.001). The dye reduction closely correlates with but is
not identical to cell replication assessed by counting or
DNA content. By 72 hours, however, this signal wanes,
and cells incubated in medium or with infectious virus
exhibit similar degrees of dye reduction (PNS). Infec-
tious virus (MOI 5) also stimulates 42% to 63% higher
cellular protein content compared to medium controls in
BALB/c mesangial cells at 48 and 72 hours, respectively.
Protein content in C57BL/6 mesangial cell lysates is 40%
higher at 48 hours after incubation with infectious virus
compared to medium controls, but no further evaluation
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Table 1. Mesangial cell proliferation exposed to Sendai virus
48 hours 72 hours
Incubation Cell number 104/well Inhibition % Cell number 104/well Inhibition %
Medium 26.6 NAa 26.0 NA
Infectious virus 32.5b NA 32.1b NA
Infectious virus  anti-IL-6 antibody 30.0 42 25.5c 100
IL-6 (200 pg/mL) 27.5 NA 31.1 NA
IL-6 is interleukin-6. Data are expressed as mean  SD.
a NA: not applicable
b t 	 2.1 vs. medium
c t  2.7 vs. infectious virus alone, P  NS vs. medium
of C57BL/6 response is undertaken. The protein content
of the viral suspensions for these experiments is much
less than 1% of the total protein recovered in the sam-
ples, and does not contribute significantly to the mea-
sured increase in protein content. Exogenous IL-6 in-
creases dye reduction at levels similar to infectious virus,
but has no significant effect on cellular protein content.
Inactivated virus has no or inconstant effects on cell
number, dye reduction or cellular protein content (data
not shown). Although addition of exogenous blocking
antibody specific for IL-6 inhibits the proliferative re-
sponse to infectious virus at 72 hours, anti-IL-6 antibody
inhibits the proliferative response at 48 hours by only
42% (Table 1).
DISCUSSION
In response to Sendai virus infection of the respiratory
tract, immunized BALB/c and C57BL/6 mice experience
a similar incidence of IgAN, yet the former develop more
severe nephritis [9]. The purpose of the present study
was to investigate potential differences between BALB/c
and C57BL/6 mesangial cells in susceptibility to Sendai
virus infection and consequent production of inflamma-
tory mediators. Our data indicate that Sendai virus can
infect mesangial cells, and in so doing up-regulates the
synthesis and release of selected mediators believed to
play a role in nephritis. Despite copious deposition of
Sendai virus antigen in the mesangium, we cannot distin-
guish infection of mesangial cells from deposition of im-
mune complexes in the experimental model [9]. How-
ever, if applicable in vivo, infection of mesangial cells
by Sendai or other viruses may elicit mediator release,
and thereby contribute to virally associated IgAN in both
mice and humans. Interestingly, both mouse strains are
equally susceptible to Sendai viral infection and fatal
bronchopneumonitis in vivo [13], and viral replication
does not differ between C57BL/6 and BALB/c mesangial
cells in vitro. Nonetheless, BALB/c mesangial cells con-
sistently produce more inflammatory mediators than
C57BL/6 mesangial cells in response to viral infection.
Therefore, the higher IL-6, JE, KC, and IP-10 responses
by BALB/c cells are not explicable by the level of viral
replication. Somehow, the genetic background might
control the metabolic response of mesangial cells [38].
Type I interferons are potent stimulators of a variety of
cytokines and chemokines, with IL-6, MCP-1/JE, and
IL-8/KC notable among them. In addition to IFN-,
IFN- has very similar effects and is generally recognized
as being regulated via the same pathways as IFN-
[39, 40]. Both IFN- and IFN- are prominent compo-
nents of the response to infection of most mammalian
cells by a wide array of viruses. Unfortunately, murine
IFN- is not accessible to assay at present. Although the
expression of type I interferon we observed may well
account for all of the other responses by mesangial cells
we report in response to Sendai virus infection, it is
important to note that many of these responses can ensue
independently of interferon synthesis as well [41, 42].
Indeed, at the present time, reliable distinction between
interferon-dependent and interferon-independent re-
sponses requires highly specialized transfected cell lines,
and is impractical in essentially all primary cultures. Ad-
ditional experiments beyond our present scope will be
needed to clarify these issues.
Among a variety of cytokines implicated, IL-6 and
TNF- seem most likely to participate in the pathogene-
sis of glomerular injury in IgAN [1, 3, 4, 16–21, 24, 27–29].
IL-6, a multifunctional cytokine, promotes a wide variety
of biologic responses, including cell proliferation. IL-6
may be an autocrine cofactor in the pathogenesis of
mesangioproliferative glomerulonephritis such as IgAN,
and there is correlation among IL-6 expression in renal
tissues, the level of urinary IL-6, and disease activity
[1, 3, 4, 17, 27–29]. Mesangial cells of both mouse strains
produced IL-6 in response to stimulation by infectious
but not inactivated virus. However, the higher IL-6 pro-
duction by BALB/c mesangial cells compared to C57BL/6
cells might account for the different risk for renal insuf-
ficiency between the two strains. We observed herein a
mitogenic effect of exogenous IL-6 similar to that re-
ported previously by others [16, 17]. Moreover, at a dose
that elicits IL-6 levels similar to those employed by oth-
ers, Sendai virus promoted proliferation of mesangial
cells. Although antibody that blocks IL-6 inhibited the
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proliferative response to Sendai virus, the blockade was
incomplete at earlier time points. This suggests that exog-
enous antibody is relatively ineffective in blocking auto-
crine, as compared to paracrine, growth stimulation. Al-
ternately, infectious virus may elicit an early response
that is independent of IL-6 and a later phase that requires
IL-6 stimulation. This latter view is supported by the
observation that IL-6 itself has little effect on cell number
or dye reduction at 48 hours, and requires 72 hours
for full effect. Although TNF- exerts many effects on
mesangial cells [1, 3, 4, 19, 21, 43], the potential for
mouse mesangial cells to produce TNF- is controversial
[44, 45]. Under our experimental conditions, TNF- pro-
duction by mesangial cells was undetected, even after
stimulation by IL-1.
In IgAN, several studies suggest that the infiltration of
monocytes/macrophages, in turn governed by adhesion
molecules and chemoattractants, could contribute to the
severity of glomerular injury [1, 3, 4, 25, 26, 30–33]. One
member of the CC-chemokine family, MCP-1, is a spe-
cific and powerful chemoattractant for monocytes, and
is produced by various cell types, including endothelial
cells, vascular smooth muscle cells, mesangial cells, and
renal tubular epithelial cells, as well as monocytes [25, 26,
30–33]. MCP-1 expression appears to promote monocyte
migration into the kidney, and renal MCP-1 expression
correlates well with the degree of the histologic changes,
and particularly with the severity of tubulointerstitial
lesions [25, 30–33]. Furthermore, urinary MCP-1 excre-
tion, mesangial proliferation, and interstitial infiltration
are well correlated in IgAN [31, 32]. Expression of JE,
the murine homolog of human MCP-1, is increased by
mesangial cells of both strains in response to infectious
but not inactivated virus. Furthermore, BALB/c mesan-
gial cells produced significantly more JE than C57BL/6
cells (on a per cell basis), even though C57BL/6 mesan-
gial cells produce much more JE than BALB/c mesangial
cells when stimulated with IL-1. If the effects of Sendai
virus on JE production by BALB/c compared to C57BL/6
mesangial cells apply in vivo, the greater production of
JE might underlie the propensity for renal insufficiency
in BALB/c mice.
Although basal production of KC by C57BL/6 mesan-
gial cells is significantly higher than that of BALB/c, the
responsiveness of BALB/c mesangial cells to infectious
Sendai virus exceeds that of C57BL/6 cells. KC is one
of the CXC chemokines and generally acts on neutro-
phils, but not monocytes, whereas the CC chemokines
act primarily on monocytes. Several reports indicate that
KC is expressed by mesangial cells in response to pro-
inflammatory mediators and contributes to neutrophil
activation and renal infiltration [46, 47]. In patients with
IgAN, the CXC chemokine IL-8, a human homolog of
mouse KC, is mainly observed in glomeruli, whereas
MCP-1 is expressed principally in vascular endothelial
cells, tubular epithelial cells, and infiltrating interstitial
mononuclear cells [32]. Urinary IL-8 excretion is ele-
vated only during the acute phase of IgAN and is corre-
lated with glomerular endocapillary proliferation and the
degree of hematuria [32]. Therefore, KC and JE might
be involved in the pathogenesis of IgAN at distinct
phases or in association with particular pathologic le-
sions. As for JE, the greater production of KC by
BALB/c cells may also contribute to the higher risk for
renal insufficiency of BALB/c compared to C57BL/6
mice [9].
Eicosanoids may also play a role in mediating glomer-
ular hemodynamic and proinflammatory events in glo-
merulonephritis [23, 24, 48–50]. For example, increased
PGE2 may antagonize thromboxane- and/or vasocon-
strictor peptide-induced reductions in glomerular filtra-
tion rate and renal blood flow, thereby preserving kidney
function in glomerulonephritis [51]. Moreover, PGE2 can
regulate local cell growth and influence the synthesis and
actions of cytokines produced by infiltrating and resident
glomerular cells [23, 24, 52, 53]. Infection of mesangial
cells by Sendai virus evokes enhanced synthesis of PGE2,
without affecting thromboxane. This may indicate a se-
lective increase in PGE2 isomerase activity or a plateau
of thromboxane synthase because calcium ionophore
A23187 did not significantly increase thromboxane syn-
thesis by these mouse mesangial cells [48]. Of note,
BALB/c mesangial cells produce more PGE2 than C57BL/6
cells, both in response to Sendai virus and under basal
conditions. Although increased PGE2 synthesis has mul-
tiple effects upon kidney function and we could not draw
any conclusion regarding the role of glomerular eicosa-
noids in this study, Sendai virus clearly alters arachido-
nate metabolism, which in turn might contribute to glo-
merular pathophysiology in vivo.
CONCLUSION
Cultured mesangial cells of either mouse strain pro-
duce eicosanoids, cytokines, and chemokines in response
to infectious Sendai virus. Although several factors may
contribute to renal insufficiency, the tendency of the
BALB/c cells to produce higher levels of inflammatory
mediators might underlie the proclivity of that strain
toward renal insufficiency relative to C57BL/6 mice in
the Sendai virus-induced model of IgAN. The critical
determinants of the difference in renal insufficiency be-
tween strains might be related to this result, but the role
of other factors in the pathogenesis of human IgAN such
as the aberrant glycosylation of IgA molecules, immune
complexes containing virus or viral proteins, and/or anti-
gen-specific T cells, must also be explored.
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